Imagine a smoke detector, but for viruses jumping from animals to humans. This work identifies the exact spots where wildlife and people meet to predict where the next big sickness might start. It also creates a quick test kit to catch these viruses early before they spread globally.
Current pandemic strategies focus on response after an outbreak occurs. There is a critical gap in tools that prevent spillover at the source and detect new viruses instantly at the human-animal interface.
A point-of-care virus test kit prototype and a pandemic prevention and preparedness literacy (3PL) intervention program.
If you are a diagnostic company dealing with slow lab turnaround times for new viruses — this project developed a point-of-care virus test kit prototype that identifies spillover at the earliest stages.
If you are an insurance provider dealing with unpredictable pandemic losses — this project developed predictive modelling of zoonotic spillover rates that helps quantify risk in high-risk settings.
If you are a consultancy dealing with poor community compliance during outbreaks — this project developed a pandemic prevention and preparedness literacy (3PL) intervention to reduce transmission risk.
Based on available project data, the specific unit cost or market price for the prototype test kit is not provided.
The project is currently developing a prototype. Based on available project data, industrial scaling plans are not yet detailed, though the models are intended to be generalizable to other regions like Africa and South America.
Based on available project data, specific licensing terms are not listed, but the project includes an exploitation strategy to reach target groups.
The project period runs from 2023-01-01 to 2027-12-31, indicating a multi-year development and testing cycle.
It integrates by providing point-of-care tools and literacy interventions designed for local communities and health, environment, and agriculture authorities.
The consortium is heavily academic, with 8 universities and 2 research institutes out of 11 partners. However, the inclusion of 1 industry partner (SME) and a 9% industry ratio suggests a bridge toward commercial application, specifically for the diagnostic prototype and literacy tools.
Contact NORGES MILJO-OG BIOVITENSKAPELIGE UNIVERSITET
Contact us to explore licensing the point-of-care prototype.
